Published in J Med Microbiol on February 01, 1975
Isolation and characterization of isogenic pairs of domed hemolytic and flat nonhemolytic colony types of Bordetella pertussis. Infect Immun (1982) 2.47
Effect of pyridines on phenotypic properties of Bordetella pertussis. Infect Immun (1982) 1.92
Outer membrane protein profiles of Haemophilus pleuropneumoniae. Infect Immun (1986) 1.46
Bordetella pertussis major outer membrane porin protein forms small, anion-selective channels in lipid bilayer membranes. J Bacteriol (1986) 1.25
Structure and biological properties of solubilized envelope proteins of Bordetella pertussis. Infect Immun (1983) 1.24
Heat-modifiable envelope proteins of Bordetella pertussis. Infect Immun (1986) 1.10
Surface proteins of Bordetella pertussis: comparison of virulent and avirulent strains and effects of phenotypic modulation. Infect Immun (1986) 1.02
Isolation and characterization of Bordetella avium phase variants. Infect Immun (1991) 0.90
Cloning of Bordetella pertussis outer membrane proteins in Escherichia coli. J Bacteriol (1984) 0.88
Characterization of the outer membrane proteins of Bordetella avium. Infect Immun (1992) 0.84
Role of antibodies against Bordetella pertussis virulence factors in adherence of Bordetella pertussis and Bordetella parapertussis to human bronchial epithelial cells. Infect Immun (1999) 0.83
Identification of a Bordetella pertussis bvg-regulated porin-like protein. J Bacteriol (1995) 0.82
Loss of adjuvanticity in rats for the hyperacute form of allergic encephalomyelitis and for reaginic antibody production in mice of a phenotypic variant of Bordetella pertussis. Immunology (1979) 0.80
Microtubule- and motor-dependent fusion in vitro between apical and basolateral endocytic vesicles from MDCK cells. Cell (1990) 3.07
Rapidity of antigenic modulation of Bordetella pertussis in modified Hornibrook medium. J Med Microbiol (1981) 2.16
Bordetella pertussis toxins. Pharmacol Ther (1982) 1.93
Internalization and recycling of activated thrombin receptors. J Biol Chem (1993) 1.86
Bordetella pertussis respiratory tract infection in the mouse: pathophysiological responses. J Infect Dis (1980) 1.82
A plasmid which can be transferred between Escherichia coli and Pasteurella haemolytica by electroporation and conjugation. J Gen Microbiol (1989) 1.62
Loss of protective antigen, histamine-sensitising factor and envelope polypeptides in cultural variants of Bordetella pertussis. J Med Microbiol (1976) 1.57
Modulation of Bordetella pertussis by nicotinic acid. Infect Immun (1983) 1.36
Growth and survival of Bordetella bronchiseptica in natural waters and in buffered saline without added nutrients. Appl Environ Microbiol (1991) 1.33
A protein factor associated with serum resistance in Escherichia coli. J Med Microbiol (1977) 1.29
Bordetella pertussis adenylate cyclase: purification and characterization of the toxic form of the enzyme. EMBO J (1989) 1.28
Localization of Rab family members in animal cells. Methods Enzymol (1992) 1.22
Identification of Bordetella pertussis in nasopharyngeal swabs by PCR amplification of a region of the adenylate cyclase gene. J Med Microbiol (1993) 1.21
Biogenesis of cell-surface polarity in epithelial cells and neurons. Cold Spring Harb Symp Quant Biol (1992) 1.20
Production and properties of Bordetella pertussis heat-labile toxin. J Med Microbiol (1984) 1.13
Immunochemical studies on the lipopolysaccharides of Bordetella pertussis. Can J Microbiol (1973) 1.10
Aluminium compounds as adjuvants for vaccines and toxoids in man: a review. Can J Public Health (1966) 1.05
Genomic fingerprinting of Haemophilus somnus by a combination of PCR methods. J Clin Microbiol (1997) 1.04
Assay of endotoxin by the hypothermic response of mice. Br J Exp Pathol (1971) 1.04
Long-term survival of Bordetella bronchiseptica in lakewater and in buffered saline without added nutrients. FEMS Microbiol Lett (1993) 1.02
Cloning of the adenylate cyclase genetic determinant of Bordetella pertussis and its expression in Escherichia coli and B. pertussis. Microb Pathog (1988) 1.01
Bioluminescence as a reporter of intracellular survival of Bordetella bronchiseptica in murine phagocytes. Infect Immun (1998) 0.99
Bordetella pertussis-induced hyperinsulinaemia without marked hypoglycaemia: a paradox explained. Br J Exp Pathol (1981) 0.98
Intracerebral mouse protection test for pertussis vaccine. I. Apparent absence of humoral protective antibody under the usual test conditions. Can J Microbiol (1968) 0.97
Interactions of rab5 with cytosolic proteins. J Biol Chem (1992) 0.96
Inheritance of responsiveness to pertussis HSF in mice. Int Arch Allergy Appl Immunol (1970) 0.95
Complementation of mutations in Escherichia coli and Bordetella pertussis by B. pertussis DNA cloned in a broad-host-range cosmid vector. J Gen Microbiol (1986) 0.93
Adenylate cyclase activity during phenotypic variation of Bordetella pertussis. J Gen Microbiol (1985) 0.93
Effect of the growth environment on cell-envelope components of Escherichia coli in relation to sensitivity to human serum. J Med Microbiol (1981) 0.93
Temperature responses of mice to Escherichia coli endotoxin. Br J Exp Pathol (1971) 0.93
PCR methods for rapid identification and characterization of Actinobacillus seminis strains. J Clin Microbiol (1998) 0.92
Distinct plasmid profiles of Pasteurella haemolytica serotypes and the characterization and amplification in Escherichia coli of ampicillin-resistance plasmids encoding ROB-1 beta-lactamase. J Gen Microbiol (1992) 0.91
Antitoxic and antiviral antibodies in Cohn fractions of human plasma. Clin Exp Immunol (1968) 0.89
Radiolabelling of Bordetella pertussis envelope proteins by the 125 I-lactoperoxidase method. Microbios (1976) 0.89
Intracerebral mouse protection test for petussis vaccine. II. Immunosuppression with cyclophosphamide. Can J Microbiol (1969) 0.89
The inactivation of pertussis protective antigen, histamine sensitizing factor, and lipolysaccharide by sodium metaperiodate. Can J Microbiol (1966) 0.88
Outer-membrane protein and lipopolysaccharide variation in Pasteurella haemolytica serotype A1 under different growth conditions. J Gen Microbiol (1992) 0.87
Specific PCR primers from the 16S-23S rRNA spacer region for the rapid detection and identification of Actinobacillus seminis. J Appl Microbiol (1998) 0.87
R-plasmid-mediated chromosome mobilization in Bordetella pertussis. J Gen Microbiol (1986) 0.87
Responses to Bordetella pertussis mutant strains and to vaccination in the coughing rat model of pertussis. J Med Microbiol (1994) 0.86
Effect of hyperreactivity to endotoxin on the toxicity of pertussis vaccine and pertussis toxin in mice. Vaccine (1989) 0.86
Construction of conjugative shuttle and suicide vectors for Pasteurella haemolytica and P. multocida. Gene (1994) 0.86
Availability and specificity of lipopolysaccharide on the surface of 56 degrees C heated Bordetella pertussis. Can J Microbiol (1973) 0.86
Bordetella pertussis adenylate cyclase toxin: proCyaA and CyaC proteins synthesised separately in Escherichia coli produce active toxin in vitro. Gene (1996) 0.86
A colourimetric, microplate assay for the leucotoxin of Pasteurella haemolytica. Vet Microbiol (1990) 0.86
Genetics of MuB1 and of a complement defect in inbred strains of mice. Genet Res (1966) 0.85
Chromosomal DNA from both flagellate and non-flagellate Bordetella species contains sequences homologous to the Salmonella H1 flagellin gene. FEMS Microbiol Lett (1993) 0.84
In vitro stimulation of human lymphocytes by Bordetella Pertussis. Acta Pathol Microbiol Scand C (1977) 0.84
Adjuvant and protective properties of native and recombinant Bordetella pertussis adenylate cyclase toxin preparations in mice. FEMS Immunol Med Microbiol (1999) 0.84
Extraction, distribution and biodegradation of bacterial lipopolysaccharides in estuarine sediments. Antonie Van Leeuwenhoek (1980) 0.84
Adjuvant effect of pertussis toxin on the production of anti-ovalbumin IgE in mice and lack of direct correlation between PCA and ELISA. Int Arch Allergy Immunol (1994) 0.83
Structure-function studies of the adenylate cyclase toxin of Bordetella pertussis and the leukotoxin of Pasteurella haemolytica by heterologous C protein activation and construction of hybrid proteins. J Bacteriol (1997) 0.83
Effect of anti-inflammatory agents on the haemorrhagic response of mouse skin to Bordetella pertussis heat-labile toxin. J Med Microbiol (1986) 0.82
Prenatal ethanol exposure has sex-specific effects on hippocampal long-term potentiation. Hippocampus (2013) 0.82
Factors affecting the lethality of Campylobacter fetus subspecies jejuni in mice. J Med Microbiol (1984) 0.82
Envelope proteins in Salmonella minnesota mutants. J Gen Microbiol (1975) 0.82
Release of pertussis toxin and its interaction with outer-membrane antigens. J Gen Microbiol (1987) 0.82
Allotypy and eniotypy. Nature (1966) 0.82
Immunodiffusion and immunoelectrophoretic studies of reovirus antigens. Can J Microbiol (1968) 0.82
Cough production, leucocytosis and serology of rats infected intrabronchially with Bordetella pertussis. J Med Microbiol (1994) 0.81
New perspectives on Bordetella pathogenicity. J Med Microbiol (1996) 0.81
Influence of mode of blood sampling on the immunoreactive insulin concentration in serum of Bordetella pertussis-treated mice [proceedings]. Br J Pharmacol (1979) 0.81
Comparison of virulence-associated in vitro properties of typed strains of Campylobacter jejuni from different sources. J Med Microbiol (2007) 0.81
Bactericidal action of high-power Nd:YAG laser light on Escherichia coli in saline suspension. J Appl Microbiol (2000) 0.81
Cloning of the virulence regulatory (vir) locus of Bordetella pertussis and its expression in B. bronchiseptica. FEMS Microbiol Lett (1989) 0.80
Comparison of outer-membrane proteins of Pasteurella haemolytica expressed in vitro and in vivo in cattle. Microbiology (1994) 0.80
Optimal conditions for the analysis of Pasteurella haemolytica lipopolysaccharide by sodium dodecyl sulphate-polyacrylamide gel electrophoresis. FEMS Microbiol Lett (1991) 0.80
Effect of prednisolone on the toxicity of Bordetella pertussis for mice. J Med Microbiol (1985) 0.80
Target cell specificity of the Pasteurella haemolytica leukotoxin is unaffected by the nature of the fatty-acyl group used to activate the toxin in vitro. FEMS Microbiol Lett (1998) 0.80
Interaction of Bordetella pertussis virulence components with neutrophils: effect on chemiluminescence induced by a chemotactic peptide and by intact bacteria. J Gen Microbiol (1988) 0.80
Loss of adjuvanticity in rats for the hyperacute form of allergic encephalomyelitis and for reaginic antibody production in mice of a phenotypic variant of Bordetella pertussis. Immunology (1979) 0.80
The effect of growth conditions on adenylate cyclase activity and virulence-related properties of Bordetella pertussis. J Gen Microbiol (1985) 0.80
ADP-ribosylation activity in pertussis vaccines and its relationship to the in vivo histamine-sensitisation test. Vaccine (2007) 0.80
Hypoglycaemia and acute stress-induced hyperinsulinaemia in mice infected with Bordetella pertussis or treated with pertussis toxin. J Endocrinol (1987) 0.79
Evaluation of different methods for the detection of outer membrane proteins and lipopolysaccharides of Pasteurella haemolytica by immunoblotting. J Immunol Methods (1994) 0.79
Inhibition of nicotinic acid and nicotinamide uptake into Bordetella pertussis by structural analogues. J Gen Microbiol (1982) 0.79
Characterisation of the leukotoxin produced by different strains of Pasteurella haemolytica. J Med Microbiol (1997) 0.79
Inactivation of bacteria and yeasts on agar surfaces with high power Nd:YAG laser light. Lett Appl Microbiol (1996) 0.78
Acellular pertussis vaccine prepared by a simple extraction and toxoiding procedure. Vaccine (1987) 0.78
Purification and partial characterization of filamentous haemagglutinin from Bordetella pertussis using monoclonal antibodies. Acta Pathol Microbiol Immunol Scand C (1984) 0.78
Bacteriolytic and bactericidal activity of sera and synovial fluids in rheumatoid arthritis and in osteoarthritis. Arthritis Rheum (1974) 0.78
Bactericidal and bacteriolytic activity of leukemic sera. Cancer Res (1973) 0.78
Lipopolysaccharide heterogeneity in Pasteurella haemolytica isolates from cattle and sheep. J Gen Microbiol (1992) 0.77
Iodination of a mixture of soluble proteins by the (125I)-lactoperoxidase technique. Biochem Biophys Res Commun (1975) 0.77
Adherence of ovine and human Bordetella parapertussis to continuous cell lines and ovine tracheal organ culture. FEMS Microbiol Lett (2001) 0.77
Slight hyperinsulinaemia but no hypoglycaemia in pertussis patients. J Med Microbiol (1988) 0.77
Differences in coughing and other responses to intrabronchial infection with Bordetella pertussis among strains of rats. Infect Immun (1997) 0.77
A novel form of ataxia oculomotor apraxia characterized by oxidative stress and apoptosis resistance. Cell Death Differ (2007) 0.77
Optimal conditions for the toxoiding of pertussis toxin with 1-ethyl-3(3-dimethylaminopropyl) carbodiimide.HCl. FEMS Microbiol Immunol (1989) 0.77
Degradation of bacterial lipopolysaccharide by gut juice os the snail Helix pomatia. Experientia (1979) 0.76
Virulence spectra of typed strains of Campylobacter jejuni from different sources: a blinded in vivo study. J Med Microbiol (2009) 0.76